Patents by Inventor Meagan B. Rouse

Meagan B. Rouse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INDOLES
    Publication number: 20130053397
    Abstract: Herein are disclosed indoles of formula (I) where the various groups are defined herein, and which are useful in treating cancer.
    Type: Application
    Filed: May 5, 2011
    Publication date: February 28, 2013
    Inventors: James Brackley, III, Joelle Lorraine Burgess, Seth Grant, Neil Johnson, Steven D. Knight, Louis Lafrance, William H. Miller, Kenneth Newlander, Stuart Romeril, Meagan B. Rouse, Xinrong Tian, Sharad Kumar Verma
  • INDAZOLES
    Publication number: 20130053383
    Abstract: Herein are disclosed indazoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
    Type: Application
    Filed: May 5, 2011
    Publication date: February 28, 2013
    Inventors: Celine Duquenne, Neil Johnson, Steven D. Knight, Louis Lafrance, William H. Miller, Kenneth Newlander, Stuart Romeril, Meagan B. Rouse, Xinrong Tian, Sharad Kumar Verma
  • Inhibitors of Akt activity
    Patent number: 8338434
    Abstract: Invented are novel pyrazole compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: December 25, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Mark Andrew Seefeld, Meagan B. Rouse
  • Inhibitors of Akt activity
    Patent number: 8273782
    Abstract: Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Grant
    Filed: February 7, 2008
    Date of Patent: September 25, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Mark A. Seefeld, Meagan B. Rouse, Dirk A. Heerding
  • INHIBITORS OF AKT ACTIVITY
    Publication number: 20110160256
    Abstract: Invented are novel hetero-pyrrole compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Application
    Filed: June 24, 2009
    Publication date: June 30, 2011
    Inventors: Meagan B. Rouse, Mark A. Seefeld
  • INHIBITORS OF AKT ACTIVITY
    Publication number: 20110160255
    Abstract: Invented are novel hetero-pyrrole compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Application
    Filed: June 24, 2009
    Publication date: June 30, 2011
    Inventors: Meagan B. Rouse, Mark A. Seefeld
  • INHIBITORS OF AKT ACTIVITY
    Publication number: 20110129455
    Abstract: Invented are novel pyrrole compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Application
    Filed: June 24, 2009
    Publication date: June 2, 2011
    Inventors: Hong Lin, Meagan B. Rouse, Mark A. Seefeld, Dennis S. Yamashita, Ren Xie
  • INHIBITORS OF Akt ACTIVITY
    Publication number: 20110098221
    Abstract: Invented are novel hetero-pyrrole compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Application
    Filed: June 24, 2009
    Publication date: April 28, 2011
    Inventors: Hong Lin, Meagan B. Rouse, Mark A. Seefeld, Ren Xie
  • INHIBITORS OF Akt ACTIVITY
    Publication number: 20110092423
    Abstract: Invented are novel hetero-pyrrole compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Application
    Filed: June 24, 2009
    Publication date: April 21, 2011
    Inventors: Meagan B. Rouse, Mark A. Seefeld
  • Inhibitors of AKT Activity
    Publication number: 20110071182
    Abstract: Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Application
    Filed: December 23, 2008
    Publication date: March 24, 2011
    Inventors: Mark A. Seefeld, Meagan B. Rouse, Dirk A. Heerding
  • INHIBITORS OF AKT ACTIVITY
    Publication number: 20110053972
    Abstract: Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Application
    Filed: February 7, 2008
    Publication date: March 3, 2011
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Mark Andrew Seefeld, Meagan B. Rouse
  • INHIBITORS OF Akt ACTIVITY
    Publication number: 20100267759
    Abstract: Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Application
    Filed: February 7, 2008
    Publication date: October 21, 2010
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Mark A. Seefeld, Meagan B. Rouse, Dirk A. Heerding, Simon Peace, Dennis S. Yamashita, Kenneth C. McNulty
  • Antibacterial agents
    Patent number: 7759340
    Abstract: Naphthyridine and quinoline derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Grant
    Filed: March 26, 2009
    Date of Patent: July 20, 2010
    Assignee: Glaxo Group Limited
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld
  • Antibacterial agents
    Patent number: 7709472
    Abstract: Naphthyridine and related derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Grant
    Filed: January 24, 2006
    Date of Patent: May 4, 2010
    Assignee: Glaxo Group Limited
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld
  • INHIBITORS OF Akt ACTIVITY
    Publication number: 20100041726
    Abstract: Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Application
    Filed: October 1, 2009
    Publication date: February 18, 2010
    Inventors: Mark A. Seefeld, Meagan B. Rouse, Dirk A. Heerding
  • Antibacterial agents
    Patent number: 7648980
    Abstract: Naphthyridine and related derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Grant
    Filed: January 24, 2006
    Date of Patent: January 19, 2010
    Assignee: Glaxo Group Limited
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld
  • Antibacterial agents
    Patent number: 7592334
    Abstract: Naphthyridine and related derivatives useful in the treatment of bacterial infections, particularly humans, are disclosed herein.
    Type: Grant
    Filed: January 24, 2006
    Date of Patent: September 22, 2009
    Assignee: Glaxo Group Limited
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld
  • INHIBITORS OF AKT ACTIVITY
    Publication number: 20090209607
    Abstract: Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Application
    Filed: February 7, 2008
    Publication date: August 20, 2009
    Inventors: Mark A. Seefeld, Meagan B. Rouse, Dirk A. Heerding
  • Antibacterial Agents
    Publication number: 20090181955
    Abstract: Naphthyridine and quinoline derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: March 26, 2009
    Publication date: July 16, 2009
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld
  • Antibacterial agents
    Patent number: 7511035
    Abstract: Naphthyridine and quinoline derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Grant
    Filed: January 24, 2006
    Date of Patent: March 31, 2009
    Assignee: Glaxo Group Limited
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld